A-list guests like Laverne Cox, Tiffany Haddish, Julianne Hough, Katie Holmes and Whoopi Goldberg were seated in the front ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

Though the feather lashes are undoubtedly one of the best beauty looks from New York Fashion Week this season, the collection ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Gossamer Bio (GOSS – Research Report). The associated price ...

As the U.S. stock market navigates a period of uncertainty marked by unchanged interest rates and looming big-tech earnings, investors are keenly observing potential opportunities in various sectors.

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

在PVRI大会上展示的信息基于Gossamer Bio的新闻稿。公司将继续研究seralutinib的有效性和安全性，以满足肺动脉高压患者未得到满足的医疗需求。与所有临床研究一样，这些发现将在科学界接受进一步的审查和验证。

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...